Cargando…
Determining the Traditional Chinese Medicine (TCM) Syndrome with the Best Prognosis of HBV-Related HCC and Exploring the Related Mechanism Using Network Pharmacology
BACKGROUND: In traditional Chinese medicine (TCM), TCM syndrome is a key guideline, and Chinese materia medicas are widely used to treat hepatitis B virus- (HBV-) related hepatocellular carcinoma (HCC) according to different TCM syndromes. However, the prognostic value of TCM syndromes in HBV-relate...
Autores principales: | Wu, Zhulin, Wei, Chunshan, Wang, Lianan, He, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263254/ https://www.ncbi.nlm.nih.gov/pubmed/34306165 http://dx.doi.org/10.1155/2021/9991533 |
Ejemplares similares
-
Dominant diseases of Traditional Chinese Medicine (TCM)
por: Wang, Jianjian, et al.
Publicado: (2022) -
Systematically Exploring the Antitumor Mechanisms of Core Chinese Herbs on Hepatocellular Carcinoma: A Computational Study
por: Wu, Zhulin, et al.
Publicado: (2020) -
MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014) -
Systematic Elucidation of the Potential Mechanisms of Core Chinese Materia Medicas in Treating Liver Cancer Based on Network Pharmacology
por: Wu, Zhulin, et al.
Publicado: (2020) -
A minireview of the medicinal and edible insects from the traditional Chinese medicine (TCM)
por: Zhang, Enming, et al.
Publicado: (2023)